XXV

Motorola Solutions Reports First-Quarter 2024 Financial Results

Retrieved on: 
Thursday, May 2, 2024
Technology, Mobile, Wireless, Carriers and Services, Public Safety, Law Enforcement, Emergency Services, Wearables, Mobile Technology, Public Policy, Government, Telecommunications, IOT (Internet of Things), Software, Internet, Hardware, Security, VoIP, ESN, Investment, Risk, Motorola Solutions, District court, Court, Privacy, Legislation, Intellectual property, CMA, GAAP, News, Annual report, Intangibles, 600 (number), Complaint, System integration, Charge control, Style (visual arts), Contempt, Climate change, Radio, Human rights, Motorola, Safety, Collection, Artificial intelligence, Public expenditure, XXV, EPS, Judgement, Sale, XV, Acquisition, Bank statement, Service, Insurance

Among other things, management uses these operating results, excluding the identified items, to evaluate the performance of its businesses and to evaluate results relative to certain incentive compensation targets.

Key Points: 
  • Among other things, management uses these operating results, excluding the identified items, to evaluate the performance of its businesses and to evaluate results relative to certain incentive compensation targets.
  • Management uses operating results excluding these items because it believes these measurements enable it to make better period-to-period evaluations of the financial performance of its core business operations.
  • Motorola Solutions cautions the reader that the risks and uncertainties below, as well as those in Part I Item 1A of Motorola Solutions' 2023 Annual Report on Form 10-K and in its other SEC filings available for free on the SEC’s website at www.sec.gov and on Motorola Solutions’ website at www.motorolasolutions.com , could cause Motorola Solutions’ actual results to differ materially from those estimated or predicted in the forward-looking statements.
  • Motorola Solutions undertakes no obligation to publicly update any forward-looking statement or risk factor, whether as a result of new information, future events or otherwise.

Homology Medicines Declares Distribution to Common Stockholders

Retrieved on: 
Monday, March 18, 2024
Failure, 600 (number), Growth, Form, Risk, COVID-19, Form S-4, XXV, Security (finance), Nature, XV, Annual report, File, CVR

BEDFORD, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX) today announced that it declared a distribution to its common stockholders of record as of the close of business on March 21, 2024 of the right to receive one contingent value right (CVR) for each outstanding share of Homology common stock held by such stockholder as of such record date.

Key Points: 
  • BEDFORD, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX) today announced that it declared a distribution to its common stockholders of record as of the close of business on March 21, 2024 of the right to receive one contingent value right (CVR) for each outstanding share of Homology common stock held by such stockholder as of such record date.
  • The payment date for such distribution is expected to be March 27, 2024 (three business days after the expected closing of the merger on March 22, 2024).
  • Certain statements contained in this filing may be considered forward-looking statements within the meaning of the U.S.
  • Homology can give no assurance that the conditions to the proposed transaction will be satisfied.

Motorola Solutions Reports Fourth-Quarter and Full-Year Financial Results

Retrieved on: 
Thursday, February 8, 2024
Telecommunications, Software, Networks, Audio, Video, Data Management, Technology, Mobile, Wireless, Security, 600 (number), Public expenditure, XV, Artificial intelligence, Collection, Motorola Solutions, Acquisition, XXV, ESN, Government, Climate change, Annual report, Bank statement, Risk, Contempt, Complaint, Radio, Court, Service, EPS, Privacy, News, District court, Investment, Human rights, GAAP, Sale, Safety, Legislation, Judgement, System integration, Bankruptcy, United States bankruptcy court, Punitive damages, Style (visual arts), Intangibles, Motorola, Intellectual property, Insurance

Among other things, management uses these operating results, excluding the identified items, to evaluate performance of its businesses and to evaluate results relative to certain incentive compensation targets.

Key Points: 
  • Among other things, management uses these operating results, excluding the identified items, to evaluate performance of its businesses and to evaluate results relative to certain incentive compensation targets.
  • Management uses operating results excluding these items because it believes these measurements enable it to make better period-to-period evaluations of the financial performance of its core business operations.
  • Motorola Solutions cautions the reader that the risks and uncertainties below, as well as those in Part I Item 1A of Motorola Solutions’ 2022 Annual Report on Form 10-K, Part II Item 1A of Motorola Solutions’ 2023 Third Quarter Report on Form 10-Q, and in its other SEC filings available for free on the SEC’s website at www.sec.gov and on Motorola Solutions’ website at www.motorolasolutions.com/investors , could cause Motorola Solutions’ actual results to differ materially from those estimated or predicted in the forward-looking statements.
  • Motorola Solutions undertakes no obligation to publicly update any forward-looking statement or risk factor, whether as a result of new information, future events or otherwise.

Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

Retrieved on: 
Wednesday, January 3, 2024
Failure, 600 (number), Risk, XV, Form, File, Common stock, Calendar, COVID-19, Nature, Form S-4, Letter, Growth, XXV, Indian stock exchange, Security (finance), Auction

BEDFORD, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX) today announced that it received notification (“Nasdaq Notification”) from The Nasdaq Stock Market LLC (“Nasdaq”) on December 29, 2023 indicating that, for the last thirty (30) consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Global Select Market (Nasdaq Listing Rule 5450(a)(1)).

Key Points: 
  • Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement
    BEDFORD, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX) today announced that it received notification (“Nasdaq Notification”) from The Nasdaq Stock Market LLC (“Nasdaq”) on December 29, 2023 indicating that, for the last thirty (30) consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Global Select Market (Nasdaq Listing Rule 5450(a)(1)).
  • The Nasdaq Notification has no immediate effect on the listing of the Common Shares on the Nasdaq Capital Market.
  • In accordance with the Nasdaq Notification, Homology has a compliance period of 180 calendar days from the date of the notification letter from Nasdaq, or until June 26, 2024, to regain compliance with the requisite minimum bid price requirement.
  • If, at any time before June 26, 2024, the bid price of the Company’s common stock closes at $1.00 per share or more for a minimum of ten (10) consecutive business days, Nasdaq will provide written notification that the Company has achieved compliance with the minimum bid price requirement.

Greif, Inc. Attends Baird Global Industrial Conference; Reaffirms Fiscal Year 2023 Guidance

Retrieved on: 
Wednesday, November 8, 2023
Adjustment, Insurance, Risk, Instability, 600 (number), NYSE, Health, GIP, Pressure, News, Conference, Cyprus Securities and Exchange Commission, Greif, Inc., Information technology, COVID-19, PPS, Form 10-K, OCC, Privacy, XXV, Rationalization, Conference call, XV, Video game

DELAWARE, Ohio, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, today reaffirms that fiscal 2023 results will be within the previously provided guidance range of Adjusted EBITDA of $790 million to $820 million1 in anticipation of participation in the Baird Global Industrial Conference in Chicago, IL on Wednesday, November 8, 2023.

Key Points: 
  • DELAWARE, Ohio, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, today reaffirms that fiscal 2023 results will be within the previously provided guidance range of Adjusted EBITDA of $790 million to $820 million1 in anticipation of participation in the Baird Global Industrial Conference in Chicago, IL on Wednesday, November 8, 2023.
  • This guidance reaffirmation is attributable to performance in-line with expectations for the fiscal fourth quarter in both Paper Packaging & Services (PPS) and Global Industrial Packaging (GIP).
  • The Company will report its fiscal fourth quarter 2023 financial results after the market closes on Wednesday, December 6, 2023.
  • Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statements.

Bernhard H. Mayer Unveils the QNET 25th Anniversary Limited Edition Timepiece, a Testament to QNET's Legacy

Retrieved on: 
Monday, July 10, 2023
Swiss made, Clock, Federation of the Swiss Watch Industry, Roman, System, FH, XXV, Federation, Cobalt, Bernhard, QNET, Dust, Fashion design, Jewellery

QNET will release a limited-edition watch under its Swiss luxury brand, Bernhard H. Mayer, to celebrate the spirit of this milestone.

Key Points: 
  • QNET will release a limited-edition watch under its Swiss luxury brand, Bernhard H. Mayer, to celebrate the spirit of this milestone.
  • Each timepiece exemplifies the Bernhard H. Mayer brand's unwavering commitment to exceptional artisanry and meticulous attention to detail.
  • The watch showcases a captivating cobalt blue-hued, sunray brushed dial that prominently features the Roman numeral XXV, symbolising QNET's remarkable 25th anniversary.
  • For more information about QNET and the limited-edition Bernhard H. Mayer watch, please visit www.qnet.net and www.bernhardhmayer.com.

Caterpillar Names New Chief Sustainability Officer

Retrieved on: 
Tuesday, December 20, 2022
100,000, 2011 New Year Honours (New Zealand), Security (finance), Engineering, NYSE, Mining, Environment, Environmental Molecular Sciences Laboratory, Transport, University, Pennsylvania State University, Pacific Northwest National Laboratory, COVID-19, Institute for Energy and Transport, Construction industry of India, Failure, Xi, XXV, Bachelor of Science in Biomedical Engineering, Resources Industry Development Board, Multimedia, Regents of the University of California, Government, Energy, Doctor of Philosophy, Information technology, OEM, Hessian Ministry of Economics, Energy, Transport and Housing, Chemical engineering, Geography, Research, Caterpillar Inc., XV, Management, Renewable energy, Bank, Science, Caterpillar

Balmer-Millar succeeds Julie Lagacy, who was Caterpillar's first Chief Sustainability & Strategy officer and is retiring February 1, 2023, after nearly 35 years of dedicated service.

Key Points: 
  • Balmer-Millar succeeds Julie Lagacy, who was Caterpillar's first Chief Sustainability & Strategy officer and is retiring February 1, 2023, after nearly 35 years of dedicated service.
  • In her capacity as Chief Sustainability Officer, Balmer-Millar will report directly to Chairman and CEO Jim Umpleby.
  • "Sustainability is an important focus area of our long-term strategy for profitable growth," said Caterpillar Chairman and CEO Jim Umpleby.
  • Balmer-Millar has held several technical and business leadership positions of increased scope and responsibility over her 20-year career with Caterpillar.

Brookfield Corporation Successfully Completes Distribution of 25% Interest in its Asset Management Business

Retrieved on: 
Friday, December 9, 2022
Behavior, Health, Ix, Government, Disclosure, XXV, Vii, Safety, 100,000, Maintenance, Insurance, XV, Corporation, Legislation, Perception, Earthquake, Xi, COVID-19, Cryptocurrency, Risk management, Arrangement

Forward-looking statements are typically identified by words such as “expect”, “anticipate”, “believe”, “foresee”, “could”, “estimate”, “goal”, “intend”, “plan”, “seek”, “strive”, “will”, “may” and “should” and similar expressions.

Key Points: 
  • Forward-looking statements are typically identified by words such as “expect”, “anticipate”, “believe”, “foresee”, “could”, “estimate”, “goal”, “intend”, “plan”, “seek”, “strive”, “will”, “may” and “should” and similar expressions.
  • The estimates, beliefs and assumptions of the Corporation and the Manager are inherently subject to significant business, economic, competitive and other uncertainties and contingencies regarding future events and as such, are subject to change.
  • Neither the Corporation nor the Manager can give assurance that such estimates, beliefs and assumptions will prove to be correct.
  • The Corporation and the Manager disclaim any obligation or intention to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law.

MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders

Retrieved on: 
Thursday, December 8, 2022
Security (finance), Address, Sale, Food and Drug Administration Amendments Act of 2007, Registration statement, CRIMINAL, Growth, Form, Tripura Merger Agreement, Register, Date, Person, XXV, Business, Proxy statement, Section 10 of the Canadian Charter of Rights and Freedoms, Name, Business architecture, Plan, XV, Prospectus, Environment, Special, Proxy, Medtech, Shareholder, Communication, Failure, 100,000, Maple Avenue/Maple Lane Historic District, Risk, Holding company, Risk management, Mergers and acquisitions

New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company”) today announced that on December 7, 2022, it convened and then adjourned, without conducting other business, its special meeting of stockholders (the “Special Meeting”) in lieu of its 2022 Annual Meeting of Stockholders from December 7, 2022 to 11:00 a.m. Eastern Time on December 12, 2022. The Special Meeting is being adjourned in order to solicit more votes toward the approval to amend the Company’s amended and restated certificate of incorporation (“Extension Amendment”) to extend the date by which the Company must complete a business combination from December 22, 2022 to June 22, 2023 (or such earlier date as determined by the Board of Directors). The Company plans to continue to solicit proxies for the Special Meeting until December 12, 2022.

Key Points: 
  • New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company”) today announced that on December 7, 2022, it convened and then adjourned, without conducting other business, its special meeting of stockholders (the “Special Meeting”) in lieu of its 2022 Annual Meeting of Stockholders from December 7, 2022 to 11:00 a.m. Eastern Time on December 12, 2022.
  • The Company plans to continue to solicit proxies for the Special Meeting until December 12, 2022.
  • The record date for the Special Meeting remains the close of business on October 24, 2022 (the “Record Date”).
  • Stockholders who have previously submitted their proxy or otherwise voted and who do not want to change their vote need not take any action.

AEye Promotes T.R. Ramachandran to Chief Operating Officer

Retrieved on: 
Tuesday, December 13, 2022
Data Management, Automotive Manufacturing, Automotive, Technology, Manufacturing, Trucking, Transport, Autonomous Driving, Vehicles, Vehicle Technology, Software, Hardware, 100,000, Probability, Transport, Defense, Environment, GM, Continental, Compte rendu, Office of the Chief Executive, COVID-19, LaCorte, Multimedia, Growth, Safety, Risk, XXV, XV, Traction, Advanced driver-assistance systems, 3D printing, Management, Risk management, Omicron, Delta, Automotive industry

Ramachandran to the position of chief operating officer for the company.

Key Points: 
  • Ramachandran to the position of chief operating officer for the company.
  • Ramachandran is promoted to COO to oversee all product execution as AEye ramps product commercialization at scale (Photo: Business Wire)
    Over the past year, T.R.
  • has demonstrated an ability to move the company from the prototype stage to product commercialization, said Blair LaCorte, CEO of AEye.
  • Ramachandran, the companys chief operating officer.